• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法洛四联症患者的肠道菌群失调。

Gut Dysbiosis in Patients With Fontan Circulation.

机构信息

Department of Pediatric Cardiology National Cerebral and Cardiovascular Center Suita Japan.

Adult Congenital Heart Disease Center National Cerebral and Cardiovascular Center Suita Japan.

出版信息

J Am Heart Assoc. 2024 Sep 17;13(18):e034538. doi: 10.1161/JAHA.124.034538. Epub 2024 Sep 9.

DOI:10.1161/JAHA.124.034538
PMID:39248279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11935625/
Abstract

BACKGROUND

The process underlying Fontan pathophysiology is multifactorial and may include gut dysbiosis (GD). We investigated the presence of GD and elucidated its correlation with Fontan pathophysiology.

METHODS AND RESULTS

Gut microbiomes of 155 consecutive patients with Fontan pathophysiology and 44 healthy individuals were analyzed using 16S rRNA sequencing of bacterial DNA extracted from fecal samples. GD was evaluated on the basis of α and ß diversities of the gut microbiome and was compared with natural log-transformed C-reactive protein, hemodynamics, von Willebrand factor antigen (a bacterial translocation marker), Mac-2 binding protein glycosylation isomer (a liver fibrosis indicator), peak oxygen uptake, and heart failure hospitalization. Patients with Fontan exhibited GD in terms of α and ß diversities as compared with controls (<0.01). Reduced α diversity was associated with a failed hemodynamic phenotype, hypoxia, high natural log-transformed C-reactive protein levels, and elevated von Willebrand factor antigen and Mac-2 binding protein glycosylation isomer levels (<0.05-0.01). In addition to elevated von Willebrand factor antigen and hypoxia, decreased α diversity was independently correlated with a high natural log-transformed C-reactive protein level (<0.05), which was associated with liver imaging abnormalities and a heightened risk of heart failure hospitalization (<0.01 for both).

CONCLUSIONS

Patients with Fontan pathophysiology exhibited GD compared with healthy individuals, and GD was linked to failed hemodynamics and systemic inflammation with a poor prognosis. Therefore, GD may play a pivotal role in a failing Fontan status, including Fontan-associated liver disease, through GD-associated systemic inflammation.

摘要

背景

Fontan 病理生理学的发生机制是多因素的,可能包括肠道菌群失调(GD)。我们研究了 GD 的存在,并阐明了其与 Fontan 病理生理学的相关性。

方法和结果

采用 16S rRNA 测序技术,对 155 例 Fontan 病理生理学患者和 44 例健康个体的粪便样本中的细菌 DNA 进行分析,研究了肠道微生物组。根据肠道微生物组的α和β多样性评估 GD,并将其与自然对数转换的 C 反应蛋白、血液动力学、血管性血友病因子抗原(细菌易位标志物)、Mac-2 结合蛋白糖基化异构体(肝纤维化指标)、峰值摄氧量和心力衰竭住院进行比较。与对照组相比,Fontan 患者的肠道微生物组 α 和 β 多样性均存在 GD(<0.01)。α 多样性降低与血液动力学不良表型、缺氧、高自然对数转换的 C 反应蛋白水平以及血管性血友病因子抗原和 Mac-2 结合蛋白糖基化异构体水平升高相关(<0.05-0.01)。除了血管性血友病因子抗原升高和缺氧外,α 多样性降低还与高自然对数转换的 C 反应蛋白水平独立相关(<0.05),这与肝脏影像学异常和心力衰竭住院风险增加相关(<0.01)。

结论

与健康个体相比,Fontan 病理生理学患者存在 GD,并且 GD 与不良血液动力学和全身炎症有关,预后不良。因此,GD 可能通过与 GD 相关的全身炎症在 Fontan 功能衰竭中发挥关键作用,包括与 Fontan 相关的肝病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/50b6df2e6b75/JAH3-13-e034538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/22c465ee274f/JAH3-13-e034538-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/8318cdf562e6/JAH3-13-e034538-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/8d506ec14d95/JAH3-13-e034538-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/357fb3880730/JAH3-13-e034538-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/50b6df2e6b75/JAH3-13-e034538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/22c465ee274f/JAH3-13-e034538-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/8318cdf562e6/JAH3-13-e034538-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/8d506ec14d95/JAH3-13-e034538-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/357fb3880730/JAH3-13-e034538-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b43d/11935625/50b6df2e6b75/JAH3-13-e034538-g002.jpg

相似文献

1
Gut Dysbiosis in Patients With Fontan Circulation.法洛四联症患者的肠道菌群失调。
J Am Heart Assoc. 2024 Sep 17;13(18):e034538. doi: 10.1161/JAHA.124.034538. Epub 2024 Sep 9.
2
Impact of hemodynamics and fluid energetics on liver fibrosis after Fontan operation.血流动力学和液体能量学对 Fontan 手术后肝纤维化的影响。
J Thorac Cardiovasc Surg. 2018 Jul;156(1):267-275. doi: 10.1016/j.jtcvs.2018.02.078. Epub 2018 Mar 7.
3
Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.瞬时弹性成像可能识别出具有不良血流动力学和晚期肝纤维化的Fontan手术患者。
Congenit Heart Dis. 2014 Sep-Oct;9(5):438-47. doi: 10.1111/chd.12159. Epub 2014 Jan 13.
4
Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation.半乳糖凝集素-3在单心室Fontan循环患者中升高并与不良预后相关。
J Am Heart Assoc. 2016 Jan 11;5(1):e002706. doi: 10.1161/JAHA.115.002706.
5
Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.血液生物标志物与心功能及不良结局的相关性研究:一项年轻 Fontan 队列研究
J Am Heart Assoc. 2021 Feb;10(5):e015022. doi: 10.1161/JAHA.119.015022. Epub 2021 Feb 24.
6
Fontan-Associated Dyslipidemia.Fontan 相关血脂异常。
J Am Heart Assoc. 2021 Apr 6;10(7):e019578. doi: 10.1161/JAHA.120.019578. Epub 2021 Mar 31.
7
Dysbiosis of gut microbiota in patients with protein-losing enteropathy after the Fontan procedure.法洛四联症根治术后蛋白丢失性肠病患者肠道微生物失调。
Int J Cardiol. 2024 Feb 1;396:131554. doi: 10.1016/j.ijcard.2023.131554. Epub 2023 Oct 22.
8
Alterations in Liver Perfusion in Adults With Fontan Circulation as Assessed by Dual Cholate Clearance.通过双胆酸盐清除率评估Fontan循环成年患者的肝脏灌注改变
J Am Heart Assoc. 2025 Apr;14(7):e039479. doi: 10.1161/JAHA.124.039479. Epub 2025 Mar 21.
9
Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.在乳糜泻恒河猴模型中,饮食中的麸质诱导肠道菌群失调,同时伴有具有肠道紧密连接和细菌结合基序的微小RNA选择性上调。
Nutrients. 2016 Oct 28;8(11):684. doi: 10.3390/nu8110684.
10
Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions.经导管测量的成人Fontan循环血流动力学:与不良事件和终末器官功能障碍的关联
Congenit Heart Dis. 2016 Dec;11(6):589-597. doi: 10.1111/chd.12345. Epub 2016 Mar 2.

引用本文的文献

1
Overcoming borders: International cooperation in re-use and re-interpretation of omics data in Fontan circulation.跨越国界:法洛四联症循环中组学数据再利用和重新解读的国际合作
Int J Cardiol Congenit Heart Dis. 2025 May 5;20:100590. doi: 10.1016/j.ijcchd.2025.100590. eCollection 2025 Jun.
2
The Role of the Gut Microbiota in Heart Failure: Pathophysiological Insights and Future Perspectives.肠道微生物群在心力衰竭中的作用:病理生理学见解与未来展望
Medicina (Kaunas). 2025 Apr 14;61(4):720. doi: 10.3390/medicina61040720.
3
Fontan-Associated Liver Disease.

本文引用的文献

1
Dysbiosis of gut microbiota in patients with protein-losing enteropathy after the Fontan procedure.法洛四联症根治术后蛋白丢失性肠病患者肠道微生物失调。
Int J Cardiol. 2024 Feb 1;396:131554. doi: 10.1016/j.ijcard.2023.131554. Epub 2023 Oct 22.
2
Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis.肠道菌群失调与 Takayasu 动脉炎主动脉瘤的形成和进展有关。
Arthritis Res Ther. 2023 Mar 24;25(1):46. doi: 10.1186/s13075-023-03031-9.
3
Re-defining the Gut Heart Axis: A Systematic Review of the Literature on the Role of Gut Microbial Dysbiosis in Patients With Heart Failure.
Fontan相关肝病
Semin Liver Dis. 2025 Mar;45(1):114-128. doi: 10.1055/a-2556-4897. Epub 2025 Mar 13.
4
Blood Biomarkers as a Non-Invasive Method for the Assessment of the State of the Fontan Circulation.血液生物标志物作为评估Fontan循环状态的非侵入性方法
J Clin Med. 2025 Jan 14;14(2):496. doi: 10.3390/jcm14020496.
重新定义肠道-心脏轴:关于肠道微生物群失调在心力衰竭患者中作用的文献系统综述
Cureus. 2023 Feb 12;15(2):e34902. doi: 10.7759/cureus.34902. eCollection 2023 Feb.
4
Immune mechanism of gut microbiota and its metabolites in the occurrence and development of cardiovascular diseases.肠道微生物群及其代谢产物在心血管疾病发生发展中的免疫机制
Front Microbiol. 2022 Dec 14;13:1034537. doi: 10.3389/fmicb.2022.1034537. eCollection 2022.
5
Host-microbiome interactions: Gut-Liver axis and its connection with other organs.宿主-微生物组相互作用:肠道-肝脏轴及其与其他器官的联系。
NPJ Biofilms Microbiomes. 2022 Nov 1;8(1):89. doi: 10.1038/s41522-022-00352-6.
6
Disorders of gut microbiota in children with Tetralogy of Fallot.法洛四联症患儿的肠道微生物群紊乱
Transl Pediatr. 2022 Mar;11(3):385-395. doi: 10.21037/tp-22-33.
7
Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure.重度慢性心力衰竭患者肠道微生物群的改变
Front Microbiol. 2022 Jan 31;12:813289. doi: 10.3389/fmicb.2021.813289. eCollection 2021.
8
The Relationship among Physical Activity, Intestinal Flora, and Cardiovascular Disease.体力活动、肠道菌群与心血管疾病的关系。
Cardiovasc Ther. 2021 Oct 12;2021:3364418. doi: 10.1155/2021/3364418. eCollection 2021.
9
The Gut Microbiome of Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的肠道微生物组。
J Am Heart Assoc. 2021 Jul 6;10(13):e020654. doi: 10.1161/JAHA.120.020654. Epub 2021 Jul 2.
10
Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions.缺氧和 HIF-1 作为肠道微生物组与宿主相互作用的关键调节因子。
Trends Immunol. 2021 Jul;42(7):604-621. doi: 10.1016/j.it.2021.05.004.